- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
The South-East Asia Regional Action Plan (RAP) for HIV (2017–2021) provides a clear vision of “zero new infections, zero HIV-related deaths, and zero discrimination” and a goal of “Ending the AIDS epidemic as a public health threat by 2030”. The action plan has targets of reducing new infections to 51 000 and AIDS related deaths to 43 000 annually and increasing the number of people living with HIV on ART to 2.9 million by 2020. It promotes a people-centred approach and is grounded in principles of human rights and health equity.
This publication examines the human and financial stakes involved in the WHO South-East Asia’s quest to end AIDS as a public health threat. It explores where and how programmes are working, where our efforts are falling short, and key actions that are needed to ensure that we get on track to end the epidemic.
Keywords: HIV, AIDS, SDG, public health
This publication documents the current scenario and future trajectory of the AIDS epidemic, with a special focus on the role of key populations and the recommendations of a brainstorming session in which participants engaged in “out-of-the-box” thinking aimed at ending the AIDS epidemic by 2030. Convened by WHO South-East Asia, along with key stakeholders, experts and community representatives, and held in New Delhi, India, the meeting examined the latest trends in Asia’s HIV epidemic and response, discussed ongoing and emerging challenges, and proposed a series of actions that would put all countries on track to end the HIV epidemic by 2030.
This resource, developed by the United Nations Population Fund and Women Enabled International, provides practical and concrete guidance on the provision of inclusive and accessible services related to gender-based violence (GBV) and sexual and reproductive health and rights (SRHR) for women and young persons with disabilities. While the primary audience is GBV- and SRHR-related service providers, the guidelines are a valuable resource for all stakeholders — including those in government, international organizations, and non-governmental organizations — involved in designing, developing, implementing or advocating for GBV or SRHR services for women and young persons with disabilities.
Keywords: gender, sexual and reproductive health, women, young people
The number of countries providing harm reduction interventions to prevent drug-related death, HIV and hepatitis C has stalled since 2016, according to a new report today from Harm Reduction International (HRI). Of the estimated 15.6 million people who inject drugs worldwide, over half live with hepatitis C, and nearly 1 in 5 live with HIV.
The report, The Global State of Harm Reduction 2018, is the most comprehensive independent analysis to date on harm reduction policy and practice around the world. It reveals that just 86 countries provide needle and syringe programmes (NSP), despite injecting drug use being present in 179 countries. This marks a fall from 90 countries in 2016, with NSPs cut in Bulgaria, Laos and the Philippines.
‘Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the world over the past decade, using data from the United Nations (UN), complemented with peer-reviewed academic research and grey literature reports from civil society. The important role of civil society in the design, implementation, monitoring and evaluation of global drug policies is recognised in the 2009 Political Declaration and Plan of Action on drugs, as well as in the Outcome Document of the 2016 United Nations General Assembly Special Session (UNGASS) on drugs. It is in this spirit that the International Drug Policy Consortium (IDPC) has produced this Shadow Report, to contribute constructively to high-level discussions on the next decade in global drug policy.
Societal stigma and punitive legal frameworks often severely impede key populations’ rights to raise families free from interference and discrimination. The experiences of key population groups (gay, bisexual and other men who have sex with men, people who use drugs, sex workers, and transgender people) are diverse, and are informed by varying levels of criminalisation, stigma and discrimination, and individual factors such as socioeconomic status, gender, race, and health status. This paper explores these challenges, and provides recommendations for policymakers.
Keywords: civil society, community, justice, human rights
History has shown us that civil society that is empowered and informed is fundamental for fighting inequality, injustice and spearheading transformative social change. Civil society actors hold a mirror up to governments, reflecting back to them the real impact of policy decisions on people and communities. The watchdog role of civil society in being vigilant in policy formulation, implementation and evaluation cannot be underestimated if the interests of society’s most marginalised are to be central to decision making processes. The IDPC Secretariat remains deeply committed to our core mandate and will continue to work alongside our members and partners to fight for civil society space in drug policy forums at the national, regional and UN levels.
The global partnership’s goal is to reach zero HIV-related stigma and discrimination.
An opportunity to harness the combined power of governments, civil society and the United Nations, the global partnership will work together, using the unique skills of each constituency, to consign HIV-related stigma and discrimination to history.
The purpose of this document is to provide guidance to national AIDS programmes and partners on the use of indicators to measure and report on the country response.
The 2016 United Nations Political Declaration on Ending AIDS, adopted at the United Nations General Assembly High-Level Meeting on AIDS in June 2016, mandated UNAIDS to support countries in reporting on the commitments in the Political Declaration. The Political Declaration on Ending AIDS built on three previous political declarations: the 2001 Declaration of Commitment on HIV/AIDS, the 2006 Political Declaration on HIV/AIDS and the 2011 Political Declaration on HIV and AIDS.